Walkay Sriganesh, Wallace David Tran, Balasubramaniam Vijay Shankar Coimbatore, Maheshwari Rohit, Changulani Manish, Sarungi Martin
Department of Orthopaedics, Golden Jubilee National Hospital, Clydebank, Glasgow, Scotland, UK.
Indian J Orthop. 2022 May 28;56(8):1449-1456. doi: 10.1007/s43465-022-00655-y. eCollection 2022 Aug.
Prosthetic joint infection (PJI) following total knee arthroplasty (TKA) and total hip arthroplasty (THA) can be a devastating diagnosis. Debridement, antibiotics and implant retention (DAIR) is a preferred treatment modality for acute PJI. A retrospective analysis of infected primary arthroplasties to evaluate the success of DAIR and factors influencing its outcomes.
We retrospectively reviewed all patients who underwent DAIR for PJI at our unit between 2010 and 2018. Patients who underwent revision surgery as an index procedure, arthroscopic washout and those with less than two years of follow-up were excluded. Treatment failure was defined as revision arthroplasty for recurrence of infection within 2 years of the index procedure. Chi-square and Fischer's exact test were used to compare between patient factors and DAIR outcomes. Kaplan-Meier survival curve and log-rank test were used to analyse implant survivorship following DAIR.
Of the sixty patients (40 knees, 20 hips) who underwent DAIR, eighteen (13 knees, 5 hips) required revision arthroplasty within 2 years accounting for a success rate of 70%. Predictive factors for revision were American Society of Anaesthesiologist (ASA) score of greater than 2 (= 0.021), BMI > 35 (= 0.046), C Reactive protein (CRP) > 200 mg/L (= 0.007) and Staphylococcus aureus growth (= 0.012). The five-year survival rate for DAIR was 70%, which remained constant after two years from DAIR.
Success rate of DAIR in PJI was 70% which was comparable to similar studies in the literature. ASA > 2, BMI > 35, CRP > 200 and staphylococcus aureus growth were predictors for DAIR failure. Implant survival rate and duration were better following DAIR in early-onset PJI.
全膝关节置换术(TKA)和全髋关节置换术(THA)后发生的人工关节感染(PJI)可能是一个灾难性的诊断结果。清创、抗生素治疗和保留植入物(DAIR)是急性PJI的首选治疗方式。对感染的初次关节置换术进行回顾性分析,以评估DAIR的成功率及其影响因素。
我们回顾性分析了2010年至2018年间在本单位接受DAIR治疗PJI的所有患者。排除作为初次手术进行翻修手术的患者、关节镜冲洗患者以及随访时间少于两年的患者。治疗失败定义为在初次手术后2年内因感染复发而进行翻修关节置换术。采用卡方检验和费舍尔精确检验比较患者因素与DAIR结果。采用Kaplan-Meier生存曲线和对数秩检验分析DAIR术后植入物的生存率。
在接受DAIR治疗的60例患者(40例膝关节,20例髋关节)中,18例(13例膝关节,5例髋关节)在2年内需要进行翻修关节置换术,成功率为70%。翻修的预测因素包括美国麻醉医师协会(ASA)评分大于2(=0.021)、体重指数(BMI)>35(=0.046)、C反应蛋白(CRP)>200mg/L(=0.007)以及金黄色葡萄球菌生长(=0.012)。DAIR的五年生存率为70%,在DAIR术后两年后保持稳定。
DAIR治疗PJI的成功率为70%,与文献中的类似研究相当。ASA>2、BMI>35、CRP>200以及金黄色葡萄球菌生长是DAIR失败的预测因素。在早发性PJI中,DAIR术后植入物的生存率和持续时间更好。